Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Nested Case-control Study to Determine the Relative Risk of and Risk Factors for Interstitial Lung Disease in a Cohort of NSCLC Patients Treated With and Without Gefitinib

NCT00252759 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00252759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Nested Case-control Study to Determine the Relative Risk of and Risk Factors for Interstitial Lung Disease in a Cohort of NSCLC Patients Treated With and Without Gefitinib
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2003
Completion date
February 28, 2006
Enrollment
6,000 (estimated)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer